Inflammatory skin conditions

Fact Sheets (2)



Guidelines (2)
Tables (2)

Topical Steroids, Comparison of Potencies and Formulations

Strengths and formulations of topical steroids.

Topical Steroids, Potential Skin Sensitisers as Ingredients

Potential sensitising agents in topical steroids.

Drug Sections (1)

Inflammatory skin conditions in the News

Hidradenitis suppurativa treatment accepted for NHS use

Hidradenitis suppurativa treatment accepted for NHS use

Adalimumab (Humira) has been approved by NICE for patients with active moderate to severe hidradenitis suppurativa who have failed to respond to conventional systemic therapy.

Galantamine and serious skin reactions

Serious skin reactions have occurred in patients taking the Alzheimer's disease treatment galantamine (Reminyl), the manufacturer has stated in a letter to healthcare professionals

First licensed treatment for hidradenitis suppurativa

The licence for Humira (adalimumab) has been extended to include the treatment of active moderate to severe hidradenitis suppurativa (HS) in adults who have had an inadequate response to conventional HS therapy

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.